|
US5652258A
(en)
*
|
1995-05-30 |
1997-07-29 |
Gliatech, Inc. |
2-(4-imidazoyl) cyclopropyl derivatives
|
|
US6008240A
(en)
*
|
1997-12-15 |
1999-12-28 |
Gliatech, Inc. |
2-(1H-4(5)-imidazoyl) cyclopropyl derivatives
|
|
EP1147092A1
(en)
|
1999-01-18 |
2001-10-24 |
Novo Nordisk A/S |
Substituted imidazoles, their preparation and use
|
|
US7265115B2
(en)
|
1999-01-29 |
2007-09-04 |
Abbott Laboratories |
Diazabicyclic CNS active agents
|
|
US6908926B1
(en)
|
1999-04-16 |
2005-06-21 |
Novo Nordisk A/S |
Substituted imidazoles, their preparation and use
|
|
US6114350A
(en)
*
|
1999-04-19 |
2000-09-05 |
Nen Life Science Products, Inc. |
Cyanine dyes and synthesis methods thereof
|
|
US6437147B1
(en)
|
2000-03-17 |
2002-08-20 |
Novo Nordisk |
Imidazole compounds
|
|
US6610721B2
(en)
|
2000-03-17 |
2003-08-26 |
Novo Nordisk A/S |
Imidazo heterocyclic compounds
|
|
EP1313470A4
(en)
|
2000-08-17 |
2005-02-16 |
Gliatech Inc |
NEW ALICYCLIC IMIDAZOLE AS H 3 ACTIVE SUBSTANCES
|
|
JP2004506685A
(ja)
*
|
2000-08-21 |
2004-03-04 |
グリアテツク・インコーポレイテツド |
食欲の制御と肥満の治療のためのヒスタミンｈ３受容体逆アゴニストの使用
|
|
AU2002256967A1
(en)
*
|
2000-10-30 |
2002-09-12 |
Schering Corporation |
Treating or reducing the risk of cardiovascular disease
|
|
BR0308118A
(pt)
*
|
2002-03-01 |
2005-01-11 |
Warner Lambert Co |
Método para o tratamento de osteoartrite
|
|
EP1720847A1
(en)
*
|
2004-02-02 |
2006-11-15 |
Pfizer Products Incorporated |
Histamine-3 receptor modulators
|
|
EP1720861A2
(en)
|
2004-02-25 |
2006-11-15 |
Eli Lilly And Company |
Histamine h3 receptor antagonists, preparation and therapeutic uses
|
|
US7632857B2
(en)
|
2004-04-01 |
2009-12-15 |
Eli Lilly And Company |
Histamine H3 receptor agents, preparation and therapeutic uses
|
|
US7696234B2
(en)
|
2004-06-02 |
2010-04-13 |
Eli Lilly And Company |
Histamine H3 receptor agents, preparation and therapeutic uses
|
|
US7705025B2
(en)
|
2004-08-23 |
2010-04-27 |
Eli Lilly And Company |
Histamine H3 receptor agents, preparation and therapeutic uses
|
|
ATE418553T1
(de)
|
2004-10-18 |
2009-01-15 |
Lilly Co Eli |
Histamin-h3-rezeptor inhibitoren, ihre herstellung und therapeutische anwendungen
|
|
CA2600757C
(en)
|
2005-03-17 |
2014-02-18 |
Eli Lilly And Company |
Pyrrolidine derivatives as histamine h3 receptor antagonists
|
|
CN101151244B
(zh)
|
2005-04-01 |
2014-09-03 |
伊莱利利公司 |
组胺h3受体活性剂、制备和治疗用途
|
|
EP1707203A1
(en)
|
2005-04-01 |
2006-10-04 |
Bioprojet |
Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands
|
|
EP1717233A1
(en)
*
|
2005-04-29 |
2006-11-02 |
Bioprojet |
Histamine H3-receptor ligands and their therapeutic application
|
|
EP1717235A3
(en)
|
2005-04-29 |
2007-02-28 |
Bioprojet |
Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
|
|
CA2622597A1
(en)
*
|
2005-09-15 |
2007-03-22 |
Banyu Pharmaceutical Co., Ltd. |
Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder
|
|
EP1942104A1
(en)
|
2006-12-20 |
2008-07-09 |
sanofi-aventis |
Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals
|
|
WO2010084160A1
(en)
|
2009-01-21 |
2010-07-29 |
Oryzon Genomics S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
RU2602814C2
(ru)
|
2009-09-25 |
2016-11-20 |
Оризон Дженомикс С.А. |
Лизинспецифические ингибиторы деметилазы-1 и их применение
|
|
WO2011042217A1
(en)
|
2009-10-09 |
2011-04-14 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
|
|
WO2011106574A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibitors for antiviral use
|
|
WO2011106573A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
|
AU2011244325B2
(en)
|
2010-04-19 |
2015-12-17 |
Oryzon Genomics S.A. |
Lysine specific demethylase-1 inhibitors and their use
|
|
ME03085B
(me)
|
2010-07-29 |
2019-01-20 |
Oryzon Genomics Sa |
Demetilaza inhibitori lsd1 zasnovani na arilciklopropilaminu i njihova medicinska primjena
|
|
WO2012013727A1
(en)
|
2010-07-29 |
2012-02-02 |
Oryzon Genomics S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
US9061966B2
(en)
|
2010-10-08 |
2015-06-23 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
|
EP3981395A1
(en)
|
2011-02-08 |
2022-04-13 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
|
KR102079406B1
(ko)
|
2011-10-20 |
2020-02-19 |
오리존 지노믹스 에스.에이. |
Lsd1 억제제로서의 (헤테로)아릴 사이클로프로필아민 화합물
|
|
WO2013057320A1
(en)
|
2011-10-20 |
2013-04-25 |
Oryzon Genomics, S.A. |
(hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
|
|
WO2013151982A1
(en)
|
2012-04-03 |
2013-10-10 |
Arena Pharmaceuticals, Inc. |
Methods and compounds useful in treating pruritus, and methods for identifying such compounds
|